User profiles for Janakiraman N.
 |
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery
…, M Katakowski, LJ Zhang, M Lu, N Janakiraman… - neurology, 2002 - AAN Enterprises
… Rats were subjected to MCAO with 3 × 10 6 hMSC (n = 9) or 3 × 10 6 rat liver fibroblasts (n
= 9; control) injected at 1 day or MCAO alone without cell donors (n = 10; control). Rats were …
= 9; control) injected at 1 day or MCAO alone without cell donors (n = 10; control). Rats were …
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
…, JA Neidhart, N Janakiraman… - Blood, The Journal …, 1997 - ashpublications.org
IDEC-C2B8 is a chimeric monoclonal antibody (MoAb) directed against the B-cell–specific
antigen CD20 expressed on non-Hodgkin's lymphomas (NHL). The MoAb mediates …
antigen CD20 expressed on non-Hodgkin's lymphomas (NHL). The MoAb mediates …
Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma
…, A Raubitschek, N Janakiraman… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: Yttrium-90 ibritumomab tiuxetan (IDEC-Y2B8) is a murine immunoglobulin G1
kappa monoclonal antibody that covalently binds MX-DTPA (tiuxetan), which chelates the …
kappa monoclonal antibody that covalently binds MX-DTPA (tiuxetan), which chelates the …
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
LD Piro, CA White, AJ Grillo-Lopez, N Janakiraman… - Annals of …, 1999 - Elsevier
Background Rituximab is a chimeric monoclonal antibody directed against the B-cell CD20
antigen which has been utilized for therapy of B-cell non-Hodgkin's lymphoma (NHL). A …
antigen which has been utilized for therapy of B-cell non-Hodgkin's lymphoma (NHL). A …
The effect of return policy leniency on consumer purchase and return decisions: A meta-analytic review
… The high N FS for both effects suggests that publication bias is not a problem. Given the
heterogeneity present within the dataset ( χ p u r 2 = 469.25 , df = 74, p < .01) ( χ r e t 2 = 1859.82 …
heterogeneity present within the dataset ( χ p u r 2 = 469.25 , df = 74, p < .01) ( χ r e t 2 = 1859.82 …
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production
X Gao, YX Xu, N Janakiraman, RA Chapman… - Biochemical …, 2001 - Elsevier
trans-Resveratrol, a phytoalexin found in grapes, wine, and other plant products, has been
shown to have anti-inflammatory, antioxidant, and antitumor activities. Many of these …
shown to have anti-inflammatory, antioxidant, and antitumor activities. Many of these …
Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a 90Y-labeled Anti-CD20 Monoclonal Antibody
…, C Emmanouilides, A Raubitschek, N Janakiraman… - Clinical cancer …, 1999 - AACR
Approximately 55,400 new cases of non-Hodgkin's lymphoma (NHL) are diagnosed each
year, with the overall prevalence of the disease now estimated to be 243,000. Until recently, …
year, with the overall prevalence of the disease now estimated to be 243,000. Until recently, …
Novel optimization approach for stock price forecasting using multi-layered sequential LSTM
Stock markets can often be one of the most volatile places to invest. Statistical analysis of
past stock performance and external factors play a major role in the decision to buy or sell …
past stock performance and external factors play a major role in the decision to buy or sell …
Spillover effects: How consumers respond to unexpected changes in price and quality
N Janakiraman, RJ Meyer… - Journal of Consumer …, 2006 - academic.oup.com
… Narayan Janakiraman is assistant professor of marketing at the Eller College of Management,
University of Arizona, 320L McClelland Hall, 1120 East Helen Street, Tucson, AZ 85721 (…
University of Arizona, 320L McClelland Hall, 1120 East Helen Street, Tucson, AZ 85721 (…
The role of inflammation in colon cancer
NB Janakiram, CV Rao - Inflammation and cancer, 2014 - Springer
Colorectal cancer (CRC) is the one of the leading causes of cancer-related deaths in the
world. CRC is responsible for more than 600,000 deaths annually and incidence rates are …
world. CRC is responsible for more than 600,000 deaths annually and incidence rates are …